These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 30247793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia.
    Varga VE, Lőrincz H, Zsíros N, Fülöp P, Seres I, Paragh G, Balla J, Harangi M.
    Lipids Health Dis; 2016 Oct 18; 15(1):182. PubMed ID: 27756331
    [Abstract] [Full Text] [Related]

  • 3. Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.
    Cauza E, Jansen M, Resch U, Dunky A, Derfler K, Winklhofer-Roob BM, Kostner K.
    J Clin Apher; 2004 Oct 18; 19(4):174-9. PubMed ID: 15597350
    [Abstract] [Full Text] [Related]

  • 4. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Aukrust P, Retterstøl K, Ose L, Halvorsen B, Holven KB.
    J Clin Lipidol; 2013 Oct 18; 7(2):109-16. PubMed ID: 23415429
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.
    Orsoni A, Saheb S, Levels JHM, Dallinga-Thie G, Atassi M, Bittar R, Robillard P, Bruckert E, Kontush A, Carrié A, Chapman MJ.
    J Lipid Res; 2011 Dec 18; 52(12):2304-2313. PubMed ID: 21957200
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.
    Kobayashi J, Katsube S, Shimoda M, Furuhashi K, Kitano S, Masuda M, Maruyama T, Shinomiya M.
    Clin Chim Acta; 2002 Jul 18; 321(1-2):107-12. PubMed ID: 12031599
    [Abstract] [Full Text] [Related]

  • 10. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Moriarty PM, Luyendyk JP, Gibson CA, Backes JM.
    Am J Cardiol; 2010 Jun 01; 105(11):1585-7. PubMed ID: 20494666
    [Abstract] [Full Text] [Related]

  • 11. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.
    Solichová D, Bláha M, Aufartová J, Krcmová LK, Plíšek J, Honegrová B, Kasalová E, Lánská M, Urbánek L, Sobotka L.
    J Nutr Sci Vitaminol (Tokyo); 2015 Jun 01; 61(2):105-12. PubMed ID: 26052140
    [Abstract] [Full Text] [Related]

  • 12. Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia.
    Frénais R, Maugeais C, Ouguerram K, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.
    Metabolism; 2001 Jun 01; 50(6):635-9. PubMed ID: 11398137
    [Abstract] [Full Text] [Related]

  • 13. Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients.
    Juhász I, Ujfalusi S, Seres I, Lőrincz H, Varga VE, Paragh G, Somodi S, Harangi M, Paragh G.
    Biomolecules; 2022 Jan 12; 12(1):. PubMed ID: 35053264
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 12; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 16. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis.
    Bräutigam C, Engelmann B, Reiss D, Reinhardt U, Thiery J, Richter WO, Brosche T.
    Atherosclerosis; 1996 Jan 05; 119(1):77-88. PubMed ID: 8929259
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol.
    Opole IO, Belmont JM, Kumar A, Moriarty PM.
    Am J Cardiol; 2007 Nov 01; 100(9):1416-8. PubMed ID: 17950800
    [Abstract] [Full Text] [Related]

  • 19. Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis.
    Kawashiri MA, Nohara A, Higashikata T, Tada H, Nakanishi C, Okada H, Konno T, Sakata K, Hayashi K, Inazu A, Mabuchi H, Yamagishi M.
    Atherosclerosis; 2017 Oct 01; 265():225-230. PubMed ID: 28926730
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.